Dr. Lipton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Russo Building
1300 Morris Park Ave. Ste. 3
Bronx, NY 10461Phone+1 718-430-3886
Summary
- I am a board certified academic neurologist. My clinical practice is focused on headache medicine. My research focuses on headache medicine, cognitive aging and dementia. After attending the University of Chicago Pritzker School of Medicine, I completed a neurology residency at Einstein, fellowships in clinical neurophysiology (at Einstein) and neuroepidemiology (at Columbia) and have been Einstein faculty ever since. I am currently the Edwin S. Lowe Professor of Neurology, Professor of Epidemiology and Population Health and Professor of Psychiatry and Behavioral Sciences at Einstein. I conduct longitudinal epidemiological studies and clinical trials funded by the NIH, the FDA and industry.
Education & Training
- Montefiore Medical Center/Albert Einstein College of MedicineResidency, Neurology, 1981 - 1986
- Northwestern UniversityMD, Medical internship, 1980 - 1981
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1980
- U of IllinoisBS, Biology, 1971 - 1975
- U of IllinoisBS, Biology, 1971 - 1975
Certifications & Licensure
- NY State Medical License 1983 - 2026
- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 114 citationsTracing transformation Chronic migraine classification, progression, and epidemiologyRichard B. Lipton
Neurology. 2009-02-03 - 55 citationsImpact of NSAID and Triptan Use on Developing Chronic Migraine: Results From the American Migraine Prevalence and Prevention (AMPP) StudyRichard B. Lipton, Daniel Serrano, Robert A. Nicholson, Dawn C. Buse, M. Chris Runken
Headache. 2013-11-01 - 421 citationsCutaneous allodynia in the migraine population.Richard B. Lipton, Marcelo E. Bigal, Sait Ashina, Rami Burstein, Stephen D. Silberstein
Annals of Neurology. 2008-02-01
Press Mentions
- Ubrogepant Taken Early May Improve Outcomes in MigraineSeptember 20th, 2024
- Ubrogepant Offers Early Relief for Migraine SufferersAugust 30th, 2024
- Ubrogepant Administered During Prodrome Beneficial for MigraineAugust 29th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: